You can filter the data below or go straight to the results. Descriptions of the various cell types we distribute, such as CPLs and LCLs, can be found here. Information on ordering biomaterials can be found here.
To share these results with others, including any filters applied, click the box below to copy a link to this page to your clipboard:
Cell type descriptions (LCLs, CPLs, etc) can be found here.
Distribution | Subjects | With DNA | Plasma | LCLs | CPLs | Whole Blood |
---|---|---|---|---|---|---|
Opioid Dependence | 7,971 |
6,556 (82%) |
2 ( 0%) |
3,189 (40%) |
4,240 (53%) |
3,860 (48%) |
Total | 7,971 |
6,556 (82%) |
2 ( 0%) |
3,189 (40%) |
4,240 (53%) |
3,860 (48%) |
Item | Value |
---|---|
Subjects | 7,971 |
With DNA | 6,556 (82%) |
Instrument: DSM-IV | 6,153 (77%) |
Instrument: DSM-III-R | 22 (0%) |
Instrument: Unknown | 1,796 (23%) |
Females / Males / Unknown | 3,034 (38%) / 4,935 (62%) / 2 (0%) |
Age | Average: 38.7, Min: 17, Max: 111 |
Race/Ethnicity | Subjects |
---|---|
White Non-Hispanic | 2,621 (33%) |
Asian | 1,956 (25%) |
White Hispanic | 1,321 (17%) |
African-American | 1,054 (13%) |
Other | 805 (10%) |
Missing | 208 ( 3%) |
American Indian | 6 ( 0%) |
Cell type descriptions (LCLs, CPLs, etc) can be found here.
Cell Type | Subjects |
---|---|
LCL | 3,189 (40%) |
CPL | 4,240 (53%) |
LCL gDNA | 3,127 (39%) |
WB gDNA | 4,055 (51%) |
Plasma | 2 ( 0%) |
Whole Blood | 3,860 (48%) |
Disease | Affected* | Unaffected | Other |
---|---|---|---|
Alcohol Dependence | 1,565 (20%) |
4,240 (53%) |
2,166 (27%) |
Cannabis Dependence | 1,336 (17%) |
1,856 (23%) |
4,779 (60%) |
Cocaine Dependence | 1,780 (22%) |
3,175 (40%) |
3,016 (38%) |
Nicotine Dependence | 1,102 (14%) |
764 (10%) |
6,105 (77%) |
Opioid Dependence | 4,790 (60%) |
1,385 (17%) |
1,796 (23%) |
Other Drug Dependence | 95 ( 1%) |
548 ( 7%) |
7,328 (92%) |
Sedative Dependence | 720 ( 9%) |
3,405 (43%) |
3,846 (48%) |
Stimulant Dependence | 824 (10%) |
3,318 (42%) |
3,829 (48%) |
Alcohol Abuse | 1,223 (15%) |
4,680 (59%) |
2,068 (26%) |
Cannabis Abuse | 686 ( 9%) |
3,469 (44%) |
3,816 (48%) |
Cocaine Abuse | 981 (12%) |
3,947 (50%) |
3,043 (38%) |
Opioid Abuse | 906 (11%) |
3,392 (43%) |
3,673 (46%) |
Other Drug Abuse | 66 ( 1%) |
577 ( 7%) |
7,328 (92%) |
Sedative Abuse | 125 ( 2%) |
1,257 (16%) |
6,589 (83%) |
Stimulant Abuse | 66 ( 1%) |
1,325 (17%) |
6,580 (83%) |
*The definition of affected depends on the study and is shown in the study breakdown below (unless hidden via the option above).
Cell type descriptions (LCLs, CPLs, etc) can be found here. The "Definition of Affected" refers to the primary phenotype of the study.
Study | Name | PI | Definition of Affected | N | With DNA | Plasma | LCLs | CPLs | Whole Blood |
---|---|---|---|---|---|---|---|---|---|
3 | Molecular Genetics of Heroin Dependence in China | Ming Tsuang | DSM Opioid Dependence | 1,929 |
1,232 (64%) |
0 ( 0%) |
1,097 (57%) |
3 ( 0%) |
222 (12%) |
5 | Addictions, Genotypes, Polymorphisms, and Function | Mary Jeanne Kreek | DSM Opioid Dependence | 1,751 |
1,751 (100%) |
2 ( 0%) |
768 (44%) |
1,708 (98%) |
1,012 (58%) |
14 | Genome-Wide Analysis for Addiction Susceptibility Genes | Herb Lachman | DSM Opioid Dependence | 1,405 |
693 (49%) |
0 ( 0%) |
598 (43%) |
640 (46%) |
116 ( 8%) |
17 | Opioid Dependence | Wade Berrettini | DSM Opioid Dependence | 204 |
200 (98%) |
0 ( 0%) |
70 (34%) |
191 (94%) |
99 (49%) |
18 | Opioid Dependence: Candidate Genes and G x E Effects | Elliot Nelson | DSM Opioid Dependence | 1,896 |
1,895 (100%) |
0 ( 0%) |
500 (26%) |
954 (50%) |
1,627 (86%) |
24 | START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies (START) | Wade Berrettini | DSM Opioid Dependence | 786 |
785 (100%) |
0 ( 0%) |
156 (20%) |
744 (95%) |
784 (100%) |
Total | 7,971 |
6,556 (82%) |
2 ( 0%) |
3,189 (40%) |
4,240 (53%) |
3,860 (48%) |
cell_file
version: 2023-11-14 #2